57 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
by the Company. Where the Company has control over an investee, it is classified as a subsidiary. The Company controls an investee if all three of the following … as at September 24, 2019. The CVRs have been classified as a financial liability in the Condensed Consolidated Statement of Financial Position. Given
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
, it is classified as a subsidiary. The Company controls an investee if all three of the following elements are present: power over an investee, exposure or rights … of the acquisition and, accordingly, have been based on fair value as at September 24, 2019. The CVRs have been classified as a financial liability
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
5:06pm
provides otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:58pm
otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b … classified as partnership for U.S. federal income tax purposes or investors therein;
persons who own or are deemed to own, directly or indirectly, 10
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:57pm
otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b) in the case … . Holders whose functional currency is not the U.S. dollar;
any entity or arrangement classified as partnership for U.S. federal income tax purposes
F-3
jraph7ooac 2whir
11 May 22
Shelf registration (foreign)
5:22pm
POS AM
4gw rpya88j47xvl
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
soiubjz4rcr xb87zm
11 May 22
Prospectus update (post-effective amendment)
5:19pm
6-K
EX-99.2
6a43eu
11 May 22
Current report (foreign)
4:30pm
424B3
jikvl4m2y8i7q
4 May 22
Prospectus supplement
8:35am
424B3
1q3 wwuu4a
4 May 22
Prospectus supplement
7:45am
6-K
EX-99.1
eg92xt 7u5
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
424B3
00osqwt056bfbc2joub8
9 Mar 22
Prospectus supplement
9:26am
424B3
6j3r2bfj ezxhwfbq6
9 Mar 22
Prospectus supplement
9:25am
6-K
EX-99.1
s9l7a z5j8ze77dcfkh9
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
6-K
EX-99.1
6bj600rg
25 Feb 22
Current report (foreign)
4:05pm
424B3
66jyyo5ipg9
3 Nov 21
Prospectus supplement
7:33am
424B3
57mc5at4 8j7a2w
3 Nov 21
Prospectus supplement
7:32am